Cardiovascular Disease II (CVD II) Flashcards

1
Q

What are the layers that make up arteries? What are its properties?

A

Arteries

3 layers - Intima, media, adventia

Strong, smooth, flexible - required to resist larger pressures

High pressure system

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How do arteries change as you move away from the heart?

A

Changes in thickness as you move away from the heart

  1. Near the heart – elastic
  2. Further away – increased muscularity
  3. Even further away (small arteries & arterioles) – fewer muscle cells, softer, thinner
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are examples of large, medium and small arteries?

A

Medium vessels – all the arteries that have a name but aren’t considered to be large

Small vessels - end of circulation

Why is this important?
- Vascular pathology is categorized based on vessel size

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Why does a blockage in a larger artery have more implications than blockages in smaller arteries?

A

The main arteries are key routes for perfusion with limited collaterals - no alternative routes

Smaller arteries have many anastomoses - Blood can reach target organs by several routes

Note - Collateral circulation can compensate for occlusion of the main system in some circumstances

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What vessel is largely responsible for change the perfusion of organs/tissues?

A

Arterioles - acts like a sphincter that changes the level of tissue perfusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How can arterial diseases be divided?

A

Arterial disease is common

  1. Can be divided according to vessel diameter (small, medium, large)
  2. Can be divided according to pathology
  3. Can be congenital or acquired
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What do the following terms means (related to arterial disease):
1. aneurysm
2. stenosis
3. occluded
4. dissection
5. vasospasm
6. vasculitis

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are aneurysms? What are typical causes? Why do we care about them?

A

Definition = 1.5 x the normal diameter

Can compare the diameters between left and right arteries – is one significantly bigger than the other

Degenerative aneurysms are the most common - breakdown of the wall

Other causes
- Inflammatory, mycotic (infective), traumatic aneurysms
- Connective tissue disease – Marfans, Loeys-Dietz, Elhers Danlos IV

Important
Dilatation/Larger in size results in a thinner wall – eventually leads to a rupture - leading to a haemorrhage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How can an anuerysm be treated?

A
  1. Replace the section of blood vessel with a new artificial polyester tubbing
  2. Endovascular repair - stent introduced – lines the inside of the blood vessel
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the most common site of a aneurysm?

A

Aneurysms can present anywhere in the body

Abdominal most common
Second most common – popliteal artery aneurysm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the most common cause of artery stenosis?

A

Atherosclerosis

  1. Lipid deposits
  2. Cholesterol rich plaque
  3. Calcification
  4. Plaque rupture (very thrombogenic) = occlusion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is claudication?

A

Claudication - ANGINA of the leg! - Most common presentation for peripheral vascular stenosis

  • Pain on walking a fixed distance
  • Worse uphill
  • Eases rapidly when you stop
  • Can progress to pain at rest/when sleeping

Noctural pain – heart rate drops/blood pressure drops resulting in pain/numbness - patients will start sleeping with the leg hanging from the bed/sleeping in a chair

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the treatment of claudication?

A

Treatment for claudication

  1. Stop smoking
  2. Physical activity – walking – the more you walk – the more you develop the collateral supply
  3. Anti-platelet agent – blood flow around clot improves
  4. Statins – good at vascular remodeling/smooths out vessels and prevent rupturing
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the acute presentations of peripheral artery occlusion?

A

Acute
1. Pain (sudden onset)
2. Palor
3. Perishingly cold
4. Parasthesia
5. Pulselessness
6. Paralysis - loss of movement
The SIX P’s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the chronic presentations of peripheral artery occlusion?

A

Chronic
1. Short distance claudication
2. Nocturnal pain
3. Pain at rest
4. Numbness
5. Tissue necrosis
6. Gangrene
Things falling off

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the treatments for peripheral artery stenosis?

A
  1. Stretch open the existing artery - balloon system
  2. Bypass graft using veins
  3. Unable to return the blood supply – amputation - related to significant morbidity and mortality
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What happens during a arterial dissection? How is it treated?

A

Intima layer breaks open resulting in blood entering between the layers of the artery – creating a true and false lumen

Bigger lumen (false lumen) – higher pressure and squeezes the true lumen

Treatment - introduce a stent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What happens during arterial vasopasm?

A

Over sensitive = vasospasm

  • Over active vasoconstriction
  • Capillary beds shut down
  • Triggers – cold, stress
  • Possible underlying connective tissue disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What happens in arterial vasculitis? What are the three types?

A

Vasculitis = Inflamed arteries - divided up by size

Large vessel – Takayasu’s disease – “the pulseless disease” - arteries loss their elasticity

Medium vessel – Giant Cell Arteritis / Polymyalgia Rheumatica

Small vessel – lots of polyangiitis conditions usually involving the kidneys

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What are the treatments for vasculitis?

A

Steroids and other immunosuppressive agents

Avoid operating or endovascular treatment if possible

Approach
1. Rheumatologist
2. Nephrologist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What are the different causes of ‘broken arteries’?

A
  1. Trauma
  2. Self-inflicted
  3. Iatrogenic - medical exmination/treatment cause
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What is the link between diabetes and arterial disease?

A

Diabetes and Arterial Disease

Diabetic patients are 20 times more likely to have an amputation
The diabetic foot is almost a speciality in its own right!

Diabetic foot - Small vessel arterial disease
- observe calcified vessels - it is Neuropathic (no pain), Ischaemic (tissue hypoperfusion), and infected
- Charcot Foot – end stage diabetic foot changes - Neuropathic, warm (Due to AV shunting - connection between artery and vein) and multiple fractures (don’t bare weight properly)

Plus patients can sometimes not see their feet due to retinopathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What are the characteristics/properties of veins?

A
  • Three layers – adventia, media, intima
  • Thin walled
  • Large expandable lumen - possible due to low smooth muscle content in walls
  • Not so circular
  • Low pressure
  • VALVES
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

How can veins be organised in accordance with size?

A

Veins have tributaries (not branches) and increase in size

Small vessels
Blood veins in the hand and foot, the kidneys, the brain, the eye

Medium vessels
mesenteric, renal, femoral, popliteal, tibial, subclavian, brachial

Large vessels
Vena cava, great veins in chest, iliacs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Do veins have a lot of different anastomoses? If yes, what implications does this have?

A

Veins have many, many anastomoses

Blood can drain from organs by many routes

Collateral circulation can compensate for occlusion of the main system in almost all circumstances

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Do veins hold a large proportion of the blood in the body?

A

Yes, there is a large venous reservoir - high capacitance system

64% of the total systemic circulation is within the veins
- 18% in the large veins
- 21% in large venous networks such as liver, bone marrow
- 25% in venules and medium sized veins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

How do veins solve the problem of gravity and return blood to the heart?

A

Venous system relies on…

  1. Muscle pumps - veins located in muscles
  2. Thoracic pump action during respiration
  3. Gravity – lying down, elevating leg to help venous return
  4. Proper functioning of the right heart
  5. Requires functioning competent valves
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

How can venous disease be categorised?

A

Venous disease is very common - 1/3 of the adult population will run into venous disease at one point

  1. Can be divided according to pathology
  2. Can be congenital or acquired
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

What is venous insufficiency? Causes?

A

Venous insufficiency - blood pooling in the legs

Can be caused by…

Failure of the calf muscle pump to pump venous blood back up the body
1. Immobility
2. Dependency
3. Fixed ankle
4. Loss of muscle mass

Failure of the valves

Results in…
Hemosiderin staining – brown discoloration of the skin – heme pigment is left behind in the skin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

What is venous hypertension? What does it result in? Clinical features?

A

Venous hypertension - elevated blood pressure in the venous system - result in increased hydrostatic pressure (moving blood/fluid out) - resulting in fluid retention and swelling

Clinical features
1. Haemosiderin staining
2. Swollen legs
3. Itchy, fragile skin
4. “Gaiter” distribution(shinpad)
5. Risk of ulceration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

What are the treatments for venous hypertension?

A
  1. Emollient to stop skin cracks
  2. Compression
    Bandages
    Wraps
    Graduated Stockings - gradient of tightness
  3. Elevate and mobilise
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

What are the two types of valve failure (think location)?

A

Superficial veins = Varicose veins

Increase blood pooling in varicose veins - sign that venous pressure is going up – very few people actually get complications

Deep veins = venous hypertension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

How can valve failure be treated?

A

Superficial veins
1. Endothermal ablation (heat treat to remove)
2. Surgical removal
3. Foam sclerotherapy
4. Adhesive occlusion
5. Compression

  • If no complications and purely cosmetic can be left alone

Deep veins
1. Compression
2. Only?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

What is Virchow’s Triad?

A

Virchow’s triad – highlights three factors that increase the risk of thrombosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Where do DVTs normally orginate? What are the risk factors for a DVT?

A

Typically pelvic/leg veins but can be axillary/subclavian upper limb DVT

Risk factors
1. Over 60
2. Smoker
3. Previous DVT
4. Right heart failure
5. Overweight
6. Cancer
7. Contraceptive Pill

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

What is Phlegmasia? How is it treated?

A

Phlegmasia is a term that has been used to describe extreme cases of lower extremity DVT, which may progress to critical limb ischemia (Venous Gangrene) and potentially limb loss.

Often with because of an underlying cancer!

Treatment – thrombolysis – break up the clot

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

How is DVT managed?

A

Standard management - anticoagulation - stops more clots from forming to allow the body to break the clot down normally

Thrombolysis (direct breakdown) also possible - using a mechanical method (shown in image) - this procedure is followed by introducing a stent.

DVT can lead to valve problems (blockage)– valves doesn’t function optimally – leading to reflux - not as problematic in calf vein DVT but more so in iliac vein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

What happens to venous return from the gut, when there is liver disease/portal hypertension?

A

Blood is diverted into the systemic venous system via anastamoses between portal vein and systemic circulation - short circuit the liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Outline the characterisitics of the lymphatic system.

A
  1. Three layers – adventia, media, intima
  2. Capillary structure
  3. Valves like veins
  4. Rhythmic contraction of smooth muscle cell pump
  5. Many, many anastomoses
  6. Drain to lymph nodes
  7. Ultimate drain to thoracic duct
  8. Thoracic duct empties to left subclavian vein

Role - drain interstitial fluid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

What is lymphoedema and what is its aetiology?

A

Lymphoedema - lymphatic channels are blocked leading interstitial fluid accumulating - swelling

Aetiology - Congenital or acquired
a) Congenital – presents at birth, puberty (Praecox) or adulthood (tarda)
b) Acquired – most common
- Post-surgery especially lymph node surgery for cancer
- Post-radiotherapy damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Worldwide what is the most common cause of lymphoedema?

A

Worldwide – most common cause is filariasis – parasitic worm that destroys your lymphatic channel and lymph nodes

UK most common cause due to medical procedures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

What is the treatment for Lymphoedema?

A

Missing treatments – mainly compression therapy and raising leg - surgery is limited

  1. Compression
  2. Skin care
  3. Exercise
  4. Manual lymphatic drainage - Specialised massage technique
  5. Rarely surgery to debulk, liposuction or connecting lymph channel to veins
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Summary - two vascular causes of a swollen limb?

A

Venous hypertension – higher pressure in venules

Lymphoedema – failure to clear interstitial fluid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

What are the two primary causes of IHD?

A

Underlying theme of IHD - narrowing of the coronary artery

Causes
1. Atheroma - stable (angine) or unstable/thrombus formation (MI)
2. Coronary artery spasm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

What are the non-phramalogical, pharmalogical and surgical treatments for coronary artery disease?

A

Non-pharmacological
Reduce modifiable risk factors e.g. diet, smoking, blood pressure

Pharmacological
- Reduce development: lipid-lowering interventions: statin, PCSK9 inhibitors, fibrates, ezetemibe
- Treat symptoms: stable angina
- Prevent thrombosis

Surgical intervention
Stent placement, balloon angioplasty for plaque removal; coronary artery bypass grafting

46
Q

What are statins? What are they used for?

A

Statins - Inhibitors of HMG-CoA (3-hydroxy-3- methylglutaryl-CoA) reductase in the liver
e.g. lovastatin, simvastatin, atorvastatin

HMG-CoA - rate limiting enzyme in LDL cholesterol biosynthetic pathway - blocking it prevents further production by liver + leads to upregulation of LDL receptors on hepatocytes = increasing clearance from circulation

47
Q

What are the side effects associated with statin use?

A
48
Q

What are PCSK9 inhibitors? How do they work?

A

Normally, PCSK9 promotes degradation of LDL bound receptors inside the cell - i.e. after binding and uptake of LDL by receptor, receptor is degraded (PCSK9 drives this)

PCSK9 inhibitor blocks PCSK9 binding to the LDL receptor – results in the LDL receptor not being degraded – means that cholesterol is taking up but the receptors are recycled and brought to the surface – increasing LDL uptake from circulation

Monoclonal antibody (Evolocumab) first used
Nowadays small interfering RNAs (Inclisiran) are also used - 2x injection per year

49
Q

What are fibrates? How do they work?

A

Fibrates e.g. gemfibrozil, fenofibrate

  1. Decrease circulating LDL and triglyceride, only small effect on LDL
  2. Increase ‘protective’ high density lipoprotein (HDL)

How?
1. Activate peroxisome proliferator-activated receptors (PPARα) - increase lipid metabolism
2. Increase expression of genes associated with lipid clearance, e.g. lipoprotein lipase, apoA1(component of HDL)

50
Q

What is ezetimibe? How does it work?

A

Ezetimibe - Blocks active transport of cholesterol from the gut wall to the liver, without affecting absorption of fat soluble vitamins, triglycerides or bile acids

Blocks
1. Blocks NPC1L1 protein on the gastrointestinal tract epithelial cells and in hepatocytes
2. Blocks aminopeptidase N and interrupts a caveolin 1–annexin A2 complex involved in trafficking cholesterol

Note on how it is used:
Added to statin where response is inadequate alone

51
Q

What is angina pectoris?

A
52
Q

What measures/treatments? can be used to reduce the ‘demand’ on the heart during angina pectoris? Think acutely and as a prophylatic

A

Reduce demand - most effective way of treating angina (relative to increasing supply)

Either by…
- Reduce heart rate or force of contraction
- Reduce preload (blood volume and venous tone - increased constriction more return) or afterload (tone of arterioles)

Acute during the attack
1. Rest
2. Rapid acting organic nitrate e.g.Glyceryl Trinitrate

Prophylactic - reduce likelihood of attack
1.Targets blood vessels
a) longer lasting nitrate
b) KATP channel opener
2. Targets heart
a) β adrenoreceptor antagonist
b) Calcium ‘antagonist’
c) ‘funny’ channel blocker

53
Q

How do nitrates work to relax blood vessels?

A

Nitrates - glyceryl trinitrate (sub-lingual, rapid action), isosorbide dinitrite (oral, longer lasting)

Nitrates - stimulate guanylate cyclase – increase cGMP - reduces amount of Ca2+ available - cause relaxation

Nitrates mimicking the effect of the NO that your endothelial cell is releasing

54
Q

How do nitrates help in the instance of angina pectoris?

A

Reduce venous circulation – decrease preload, reduce afterload and relaxes coronary arteries (spasm)

Main effect is on venous circulation

Glyceryl trinitrate - given acutely – not long term as it results in tolerance

55
Q

What is Nicorandi? How does it help with angina pectoris?

A

Nicorandil - Main drug use to target blood vessels

Drives hyperpolarisation of smooth muscle (opening of ATP-sensitive K+ channel) and acts as a nitrate (stimulates guanylate cyclase)

Relax preload and afterload + dilates coronary arteries – similar mode of action to nitrates but less likely to develop tolerance

56
Q

How do β-adrenoreceptor antagonists help with alleviating angina pectoris?

A

Short term - Block the effects of noradrenaline (B1 adrenoreceptor) on the heart – reduce the heart rate and therefore oxygen demand

Long term - Block Renal B1 adrenoreceptor – blocking the RAAS system – reduce volume of blood – long term

57
Q

How does Ivabradine work and how does this help with angina pectoris?

A

Less side effects than β-blockers, used as alternative or as adjunct to β blocker therapy

58
Q

How do Calcium antagonist work? How does it help with angina pectoris?

A

Block entry of calcium into cardiac muscle cells – reduce contractility – reduce O2 demand

59
Q

Recap - how is thrombus formed?

A

Blood vessel wall damage – platelets activate and stick – drives coagulation cascade to form fibrin mesh - creates plug

60
Q

Who takes anti-thrombotic drugs? What are the two categories of anti-thrombotic drugs taken?

A

Anti-thrombotic drugs - taken prophylactically to reduce the risk of thrombus if atherosclerotic plaque ruptures, in patients at high risk, or those who have already had an MI.

Usually anti-platelet (aspirin, clopidogrel, voripaxar)

But also anti-coagulant (warfarin, rivaroxaban)

61
Q

What are the steps that lead to platelet activation?

A
  1. Stimulus - damage
  2. Arachidonic acid release - using PLA2
  3. Cyclic endoperoxidases formation via COX
  4. Converted to TxA2 (thromboxane)
  5. TxA2 binds to the receptor on platlets leading to increase intracellulaer Ca2+
  6. Results in platlet activation

Site of intervention - thrombin and COX

62
Q

What happens to platelets when they start becoming activated and clump together?

A

When activated platelets change shape and release contents of granules to further increase activation e.g. adenosine diphosphate (ADP)

Furthemore, platelets express glycoprotein IIb/IIIa receptors for attachment of fibrin, from coagulation cascade to stabilise thrombus

63
Q

How can we intervene with ADP mediated platelet activation and platelet-fibrin interaction?

A

Target P2Y12 receptor - breaking positive feedback loop

Target gpIIb/IIIa - to prevent platelet-fibrin interaction

64
Q

Given your knowledge on the different players in the platelet activation pathway that can be target, what drugs are used to target those players?

A

Anti-platelet drugs - taken prophylactically to reduce the risk of thrombus

Cyclooxygenase inhibitor e.g. aspirin
-Irreversible inhibition of COX = prevents formation of TxA2 & platelet activation

P2Y12 inhibitor e.g. clopidogrel, ticagrelor
blocks effect of ADP and prevents platelet activation

Thrombin-receptor antagonist e.g. voripaxar - prevent activation of PAR-1 receptors on platelets - more reading

Risk: bleeding, newer drugs are shorter acting or reversible

65
Q

What is the aim of anti-coagulant drugs? What are the different types used?

A

Prevent the formation of fibrin to stabilise platelet plug

  1. Intravenous e.g. heparin
  2. Orally active e.g. warfarin, rivaroxaban
66
Q

How does heparin work as an anti-coagulant?

A

Body produces antithrombin 3 – neutralizes the serine proteases

Hence, heparin binds to antithrombin 3 and potentiates/activates this system - block coagulation cascade

67
Q

How does warfarin work as an anti-coagulant?

A

Warfarin – inhibits Vitamin K cycle which is required for clotting factor production

Reduced clotting factors in circulation = reduce clotting

Factors II, VII, IX, X

68
Q

What are the problems associated with warfarin use?

A
  1. Narrow optimal range – high risk of bleeding
  2. Metabolized in liver – prone to be modified by other drugs and environmental influences
  3. Blood levels need to be checked regularly
69
Q

How does the anti-coagulant rivaroxaban work?

A

Orally active anti-coagulant: direct inhibitor of factor Xa

70
Q

What is heart failure? What are the two types?

A

Heart Failure - failure of the heart to meet the demand of the body

Leading to… impaired tissue perfusion: fluid retention, breathlessness, muscle weakness etc
also arrythmia

Types:
1. HF with reduced ejection fraction (HFrEF) or systolic HF - impaired contractility and emptying of ventricle - most common and drugs directed here
2. HF with preserved ejection fraction (HFpEF) or diastolic HF - impaired relaxation and filling of ventricle - growing recognition, more common in women, diabetes, mechanisms less understood

Note - MI’s can lead to heart failure - leads to damage/necrosis of heart tissue leading to impaired function - some replacement of cardiomyocytes occurs but not enough.

71
Q

What are 5 common causes of heart failure?

A
72
Q

How are inotropic agents used to increase contractility in HF?

A

Inotropic agents to increase contractility

Example - Digoxin

Digoxin - cardiac glycosides that increase the force of contraction (+ve inotrope - increase contractility) therefore increases kidney perfusion and fluid loss

73
Q

Outline the different phases of the cardiomyocte action potential.

A

Cardiomyocyte resting membrane potential = –80 mV to –90 mV

Maintained by the balance of K+, Na+, Cl- and Ca2+ ions across the cell membrane

Action Potential
Phase 0 – sodium going into the cell
Phase 1 – transient efflux of K+ - depolarization
Phase 2 – Influx of Ca2+ and Na+ drives contraction
Phase 3 – K+ efflux – repolarization
Phase 4 – re-establishment of the correct ion levels in and outside the cell

74
Q

How do cardiac glycosides work (thinking about cardiomyoctes and action potentials)?

A

Na+/K+ ATPase is an unequal exchanger that ensures that Na levels are low within the cell - creating a concentration gradient - which can then be used to drive movement of Ca2+ out of the cell using a Na+/Ca2+ exchanger – ensures Ca2+ localises outside – ready for another contraction

Hence….

  1. Cardiac glycosides block Na+/K+ ATPase
  2. Increase intra-[Na]
  3. Results in less movement of Ca2+ outwards
  4. Results in an accumulation of Ca2+ in the cell – increase contractility

Note - acute solution but too much calcium accumulation is toxic for cardiomyocyte

75
Q

What are the two +ive iontropes used to acutely increase heart contractility in cases of heart failure?

A

Inotropes to increase contractility - acutely
1. digoxin
2. dobutamine (ß1 adrenoreceptor agonist iv for rapid response), increases heart rate and contractility

Provide support in acute heart failure, but results in increased oxygen and energy demand so NOT helpful in the long term for chronic heart failure

76
Q

Physiology - what two ways can we ‘unload’ the heart?

A
  1. Reduce Preload
  2. Reduce Afterload

Reduce load on the heart – reduction in heart failure exacerbation

77
Q

What factors influence/affect preload? What factors lead to increased preload?

A

Determined by…
1. Blood volume - RAAS & SNS
2. Venous ‘tone’ - capacity of the venous circulation to hold blood - SNS

Increased preload…
1. Sympathetic NS activation
2. Renal failure
3. Heart failure

78
Q

Outline how the RAAS effects pre-load and afterload.

A

ANGII - Constricts blood vessels increasing after-load + increase blood volume by increasing levels of aldosterone resulting in increased pre-load

79
Q

Outline how the SNS effects pre-load and afterload.

A

Sympathetic nervous system (SNS) response to decreasing blood pressure

80
Q

Outline how the SNS and RAAS feedback systems create the viscious cycle seen in chronic heart failure patients.

A

Main goal for many of drugs is to break vicious cycle

81
Q

What drugs are used to block the RAAS system?

A
  1. Renin inhibitor e.g. aliskiren
  2. ACE inhibitor e.g. enalapril, lisinopril
  3. AT receptor antagonists e.g. losartan, valsartan
82
Q

What two types of drugs are used to reduce blood volume/preload in CHF patients?

A
83
Q

What type of drugs are used to reduce the effect of the SNS in CHF patients?

A

ß adrenoreceptor antagonists: e.g. atenolol, metoprolol (ß1 selective)

  1. Reduce sympathetic drive to the heart (reduced O2 demand) - decrease HR
  2. Block renin release from the kidney, therefore decrease RAAS activation, decrease pre-load & after-load

Few side-effects, but not useful in asthmatics (especially non-selective) - high doses can activate B2 receptors – drive bronchoconstriction

84
Q

What two types of drugs are used to reduce vasoconstriction in CHF patients?

A
85
Q

How are biochemical markers used for Heart Disease risk stratification?

A

Biochemical markers are used to identify individuals who may benefit from preventative treatments i.e. Before a heart attack or stroke occurs – “primary prevention”

These markers are then combined into a risk assessment tool that indicates the liklihood that an individual will suffer from a cardiac event - e.g. Assign risk score

86
Q

What biochemical markers are currently used in risk stratification? How could these scores be improved?

A

Currently….

Markers for increased risk:
Total Cholesterol (TC)
Low Density Lipoprotein (LDL)

Markers for decreases risk:
High Density Lipoprotein (HDL)

How can risk stratification be improved?

Add in additional biochemical markers
- CRP – marker of inflammation
- Other atherogenic lipoproteins e.g. Lipoprotein a
- Troponin

Improve risk score calculations
- ASSIGN to be updated
- Other scores – QRISK3
- ?role for machine learning algorithms in the future
- ?role for Imaging

87
Q

Biomarkers for diagnosis - What are the properties of an ideal biomarker?

A
88
Q

What is the current gold standard biomarker that is used for MI?

A

Troponin - The troponin complex (3 sub-unit) is a component of the thin filaments in striated muscle complexed to actin

Cardiac specific forms – measured using Immunoassay with monoclonal antibodies

89
Q

Why is cardiac troponin useful as a tool for diagnosing MI’s?

A
  1. Very Sensitive - illustrated by image - low amounts of cardiac muscle damage to produce signal
  2. Tissue Specific (cardiac trop)
  3. Useful for early and late presentations - levels stay raised
  4. Predicts Future Cardiac Events (Risk stratification)

Note - Trop I or T seem to be equally effective - Trop C normally measured

90
Q

How is troponin used in MI diagnoses?

A

Used as a part of the diagnosis criteria
1. Based on clinical syndrome
2. ECG changes
3. Increased markers - troponin >99th percentile of the reference population (top 1% of measurments)

Note - Increasing sensitivity of troponin assays has resulted in progressively lower thresholds being used to define MI

Current NHS Lothian Trop T cut offs: 9 ng/L (women) and 16 ng/L (men) - variation in heart size between men and women

91
Q

What is the consequence of having a lower cut-off for troponin in acute mI diagnoses?

A

Results in increased numbers of patients diagnosed with AMI

Important - as at the low tropnin concentrations (0-25ng/L) - there is a linear relationship between troponin concentration and death from MI/recurrent MI

Having information at this low concentration range is valuable - helped to save lives

92
Q

What are other causes of raised troponin to keep in mind?

A
93
Q

What are the two main types of MI?

A

Type 1 and type 2 (up to 6 types)
Type 1 – classic acute thrombus MI
Type 2 MI – supply-demand imbalance – fixed Atherosclerosis, vasospasm or endothelial dysfunction

94
Q

What investigations are performed to diagnose heart failure?

A

Imaging – Measure cardiac
pressures/ejection fraction - gold standard but long waiting list
1. Echocardiography
2. MRI

Biochemical correlates of diagnosis, prognosis,treatment: Natriuretic peptides - can be measured!

95
Q

What are the different types natriuretic peptide?

A
96
Q

How are naturetic peptides used in the diagnosis of heart failure?

A

Used as a rule-out test - negative = heart failure unlikely.

97
Q

What is the future of using biomarkers in healthcare - particularly in heart disease?

A

Point of contact testing for biomarkers - more relevant for us in the future - bedside tool

Chest Pain - TROPONIN
Breathless – BNP, D-dimer

98
Q

When thinking about exercise physiology, what three systems are we interested in?

A

Exercise physiology – looking at the interaction between all these systems

99
Q

What are the three factors that influence oxygen uptake (VO2)? What is VO2 max?

A

↑EXERCISE → ↑OXYGEN DEMAND

V̇O2 (oxygen uptake) is dependent upon:
1. Ventilatory capacity to provide oxygen
2. Circulation to deliver O2 to exercising muscle
3. Muscle ability to utilise O2 for energy conversion

Maximal oxygen uptake (V̇O2 max) – Used as a global measure of fitness

100
Q

What are the two primary functions of ventilation? What is the respiratory quotient?

A

Ventilation
1. Uptake of oxygen
2. Clearance of CO2 produced

Respiratory quotient (RQ) or Respiratory Exchange Ratio (RER):
RQ = CO2/ V̇O2
CO2 produced / O2 consumed
RQ increases with exercise - CO2 clearnace increase more than O2 uptake

101
Q

How does ventilation change with increasing exercise difficulty? What is ventilation per minute?

A

Increased ventilation needed as O2 demands (V̇O2) and need to clear CO2 (V̇CO2) increase

Increased ventilation achieved by:
1. Increases in respiratory rate (RR)
2. Increased size (tidal volume - VT) of each breath
Ventilation per minute (VE)=̇ RR x VT

Minute ventilation (V̇E) may increase up to 25-fold on exercise

102
Q

What is Maximal exercise ventilation (VE max)?

A

Maximal exercise ventilation (VĖ max) - expected maximal exercise ventilation

VEmax - can be estimated from maximal voluntary ventilation (MVV) using FEV1

MVV = FEV1 x 40

103
Q

Is breathing normally a limting factor in exercise?

A

Breathing not usually an exercise-limiting factor

Maximal exercise is achieved with gas left in the tank

Other factors – cardiac, physical fitness and motivation

104
Q

What circulatory adaptations take place during exercise?

A
  1. Five-fold increase in cardiac output during exercise
    - Increases in HR
    - Increases in stroke volume
  2. Improved oxygen transfer during exercise
    - Increased blood volume within pulmonary capillaries
    - Re-distribution of blood flow to muscle
  3. Re-distribution of blood flow to peripheries
    - Increased blood flow to exercising muscles
    - Less blood flow to splanchnic circulation (gut)
105
Q

Is cardiac physiology the rate limiting factor for maximal exercise?

A

YES!
CARDIAC PHYSIOLOGY = Rate-limiting factor to maximal exercise in health

Maximal Heart Rate (HRmax) = Ceiling of Exercise

Along with efficiency of exercise performance in reaching HRmax

106
Q

What factors define our physical conditioning?

A

How our muscles take up oxygen and convert it to ATP (muscle metabolism) - dependent on…
Muscular capillaries for oxygen transfer
Mitochondria for oxygen utilisation
Oxidative enzymes for energy transformation

The efficiency of these mechanisms define our level of physical conditioning

107
Q

What is the Anaerobic Threshold? How is it measured?

A

Point at which ventilation increases at a faster rate than oxygen uptake (VO2)

and…

Reflects the point at which anaerobic metabolism begins to predominate with exponentially increasing carbon dioxide production and accumulation of fatigue-related metabolites including lactate.

Measuring anaerobic threshold:
1. Lactate Threshold - invasive
2. Gas Exchange Threshold -invasive
3. Ventilatory threshold - non-invasive

108
Q

What effects does training have on our fintess (physiologically)?

A

Training results in…
1. Improvements in cardiac stroke volume
2. Increases in the size of the muscle capillary network
3. Increased mitochondrial density
4. Increased oxidative enzyme concentrations

By improving fitness, AT is reached later in exercise
= later switch from aerobic to anaerobic metabolism
= able to exercise more efficiently

Capable of reaching greater exercise capacity

109
Q

Exercise in health - key takeaways?

A

Exercise-limiting factors
- Limited by maximum heart rate and by level of fitness/conditioning

Training can improve adaptation to exercise
- Improve our level of physical conditioning and exercise performance

110
Q

What are the key points whens thinking about exercise in disease?

A
  1. Exercise may exacerbate an underlying disease
    a) Asthma
    b) Arrhythmia
  2. Understanding exercise limitation may be important in disease
    - By impacting exercise performance, one may impact prognosis
  3. Exercise testing can inform surgical risk

Poor exercise performance and early AT may be deal-breakers to major surgery - can yield negative health outcomes

During surgery…
- Inability to meet needs for CO2 elimination (VCO2)
- Adverse myocardial effects of Lactate accumulation

111
Q

How are angiotensin receptor & neprilysin inhibitors (ARNI) use in patients with heart failure?

A

Combination of a neprilysin inhibitor (blocks break down of natriuretic peptides) and angiotensin receptor inhibitor (Block activation of RAAS system)

ARB is required as neprilysin inhibitor also block AngII break down - hence, we need to counter that

Result
1. Reduced preload
2. Reduced afterload